1. Driving Forward our COVID-19 Policy Priorities for Patients

    430,000 people – it’s a huge number. It’s the population of Minneapolis. Nine straight days of sell-out crowds at Yankee Stadium. Nearly the entire enrollment of the Southeastern Conference. And it’s the number of people who, in the last six weeks, have become newly eligible for Medicaid, thanks to successful ballot initiatives this summer in Oklahoma and Missouri. LLS, our staff, and our volunteers are proud to have played a role in this major win for patients. Those victories cou...

    Read More
  2. LLS Information Specialist Recognized by AOSW for Lifetime Achievement

    The Association of Oncology Social Work recently held its annual meeting in which recognition of social work excellence was provided through several awards. One of these awards, LLS Hematology-Oncology Lifetime Achievement Award, honors an oncology social worker who has exhibited leadership and support for blood cancers patients and has had ongoing involvement with The Leukemia & Lymphoma Society throughout their career. This year, LLS is proud to announce the Lifetime Achievement Awa...

    Read More
  3. LLS Community Reaches a Membership Milestone

    LLS celebrates its online Community members, now over 15,000 strong. LLS Community launched in 2016 to honor Michael Garil, who was diagnosed with acute lymphoblastic leukemia in 1974 at the age of 7. Throughout his life, Michael dedicated himself to openly sharing his experiences in the hopes of helping others. To continue what Michael started, his parents Ethel and Bernard Garil generously supported the creation of LLS Community in his memory. During the past four years, LLS Community ...

    Read More
  4. Celebrating Survivorship: Caitlin McClellan

    My name is Caitlin McClellan and I was diagnosed with Non-Hodgkin lymphoma in June 2015. I went through six months of chemotherapy and two years of maintenance with Rituxan. I am loving life! I got married in 2017 and went on a wonderful honeymoon to Nashville, Tennessee. While there, we decided to do a Light the Night walk and met Charles Esten! We have done many Light the Night walks. My team name even won some prizes! It is ode to the nodes!

    Read More
  5. The Leukemia & Lymphoma Society National Blood Cancer Conference

    Don't Miss The LLS Inaugural National Blood Cancer Conference-A Free VIRTUAL Educational Conference for Patients, Survivors, Caregivers and Healthcare Professionals. The conference will be held on Saturday, September 12, 2020 beginning at 11:30 am EST (ends 2:45 pm EST) and will feature expert speakers from around the country. This virtual Blood Cancer Conference (BCC) is one of many programs developed by The Leukemia & Lymphoma Society (LLS) to meet the needs of patients, surviv...

    Read More
  6. When the Insurance Says No to a Clinical Trial

    As an LLS Clinical Trial Nurse Navigator, Ashley Giacobbi works tirelessly to connect the right patient with the right clinical trial – work that has become increasingly complicated in the COVID-19 era. But recently, she went the extra mile to ensure a patient – a young healthcare worker whose AML had relapsed several times – could access a trial that offered a promising treatment option. The patient had reached out to LLS seeking a trial back in May. Giacobbi identified about 15 ...

    Read More
  7. August 2020-Patient and Caregiver Education Programs

    Please join your local chapter in the following education programs for patients and caregivers. Understanding Immunotherapy for Blood Cancers A Virtual Education Program August 24, 2020 (TXG) 6:00pm - 7:30pm (CT) https://na.eventscloud.com/ehome/558025 Managing Stress and Coping with Cancer A Virtual / Online Education Program August 25, 2020 (WI) 5:30PM – 7:00PM (CT) https://na.eventscloud.com/ehome/552293 Lymphoma: Emerging Therapies & Survivorship A Virtual Edu...

    Read More
  8. A New CAR-T Approval Brings Hope for Mantle Cell Lymphoma Patients

    The U.S. Food and Drug Administration (FDA) today announced its approval for a breakthrough treatment that will bring the promise of immunotherapy and new hope to thousands of patients diagnosed with mantle cell lymphoma (MCL) whose previous treatments fail to bring them lasting remissions. There are more than 70 subtypes of lymphoma, and MCL is a particularly aggressive form of this blood cancer with a short remission from standard therapies. The median overall survival rate is betwe...

    Read More
  9. Destroying Mutant Proteins as an Emerging Cancer Treatment: A Q&A with a New LLS TAP Partner

    Kymera Therapeutics is a biotech company pioneering an emerging approach to cancer therapy called “targeted protein degradation.” Whereas most targeted therapies inhibit or inactivate the proteins or genes that drive the cancer, targeted protein degradation harnesses the body’s natural system of ridding itself of unwanted, ‘old’ or ‘broken’ components of cells. In March 2020, LLS made a strategic investment in Kymera’s work to treat blood-based cancers through our Therapy Acce...

    Read More